Emprise Bank’s AbbVie ABBV Stock Holding History

Emprise Bank’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$346K	Hold	1,373	–	–	0.13%	78
2026 Q1	$299K	Hold	1,373	–	–	0.12%	80
2025 Q4	$314K	Sell	1,373 -1	-0.1%	-$228	0.13%	78
2025 Q3	$318K	Buy	1,374 +36	+3%	+$7.33K	0.14%	79
2025 Q2	$248K	Sell	1,338 -105	-7%	-$19.5K	0.12%	90
2025 Q1	$302K	Sell	1,443 -191	-12%	-$37.1K	0.16%	76
2024 Q4	$290K	Sell	1,634 -498	-23%	-$91.6K	0.16%	83
2024 Q3	$421K	Sell	2,132 -951	-31%	-$177K	0.24%	68
2024 Q2	$529K	Sell	3,083 -1,072	-26%	-$178K	0.33%	65
2024 Q1	$757K	Buy	+4,155	New	+$716K	0.51%	50

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Emprise Bank's ABBV Position: Q2 2026 in Review

Emprise Bank held its AbbVie (ABBV) position steady in Q2 2026 at 1,373 shares worth $346K. The position accounts for 0.13% of the portfolio, ranked #78.

Emprise Bank first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. The position peaked at $757K in Q1 2024. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Emprise Bank held 1,373 shares of AbbVie worth $346K as of Q2 2026.
Emprise Bank left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.13% of Emprise Bank's portfolio in Q2 2026, its #78 holding.
Emprise Bank first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
Emprise Bank's AbbVie position peaked at $757K in Q1 2024.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Emprise Bank's 13F filing for Q2 2026, filed 7 Jul 2026.